WuXi Biologics (Cayman) Inc
F:1FW2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
WuXi Biologics (Cayman) Inc
F:1FW2
|
CN |
|
B
|
Basf Se
DUS:BAS
|
DE |
|
U
|
Unilever Indonesia Tbk PT
XMUN:UTG
|
ID |
|
E
|
Exelixis Inc
XBER:EX9
|
US |
|
A
|
Alcoa Corp
F:185
|
US |
|
N
|
NVE Corp
XMUN:NVK
|
US |
|
L
|
Legend Oil and Gas Ltd
OTC:LOGL
|
US |
|
C
|
Corporate Office Properties Trust
F:WX7
|
US |
|
P
|
ProMIS Neurosciences Inc
F:23J0
|
CA |
|
H
|
Hongkong and Shanghai Hotels Ltd
OTC:HKSHF
|
HK |
|
N
|
Norwegian Cruise Line Holdings Ltd
XMUN:1NC
|
US |
|
F
|
ForFarmers NV
SWB:5FF
|
NL |
|
Toppan Inc
F:TPX
|
JP |
|
A
|
Air Lease Corp
F:AVLA
|
US |
|
P
|
Prolexus Bhd
KLSE:TECHBASE
|
MY |
|
A
|
Atea ASA
XMUN:MKL
|
NO |
|
Rothschild & Co SCA
F:13F
|
FR |
|
Red Planet Indonesia Tbk PT
IDX:PSKT
|
ID |
|
C
|
Columbia Sportswear Co
F:CUW
|
US |
|
CommScope Holding Company Inc
NASDAQ:COMM
|
US |
|
A
|
Advanced Micro Devices Inc
XMUN:AMD
|
US |
Wall St Price Targets
1FW2 Price Targets Summary
WuXi Biologics (Cayman) Inc
According to Wall Street analysts, the average 1-year price target for 1FW2 is 5.39 EUR with a low forecast of 3.6 EUR and a high forecast of 9.71 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1FW2's stock price target?
Price Target
5.39
EUR
According to Wall Street analysts, the average 1-year price target for 1FW2 is 5.39 EUR with a low forecast of 3.6 EUR and a high forecast of 9.71 EUR.
What is the Revenue forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
12%
Over the last 10 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 12%.
What is the Operating Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
15%
Over the last 10 years, the compound annual growth rate for Operating Income has been 61%. The projected CAGR for the next 8 years is 15%.
What is the Net Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
13%
Over the last 10 years, the compound annual growth rate for Net Income has been 60%. The projected CAGR for the next 8 years is 13%.
